Authors

Class effect is good news for men with nonmetastatic CRPC

"While much work is still to be done, we have excellent evidence that there is a beneficial class-like effect for the androgen inhibitors enzalutamide, apalutamide, and darolutamide used within the current definition of men with M0 CPRPC," write Michael Cookson, MD, and Tony Rodriguez, MD.

Long-term Survival with Immunotherapy in Advanced Prostate Cancer

Bladder Ca biomarkers and BCG: New knowledge of the urinary microbiome

Study findings have implications for noninvasive markers to predict the course of UCC

Bladder Ca biomarkers and BCG: New knowledge of the urinary microbiome

Study findings have implications for noninvasive markers to predict the course of UCC

Bladder Ca biomarkers and BCG: New knowledge of the urinary microbiome

Study findings have implications for noninvasive markers to predict the course of UCC

Challenging case: Hematuria in man with a history of prostate Ca

A 63-year-old African-American male presents to the emergency department with sudden onset of painless gross hematuria for one day. He reports dark red urine with clots causing occasional dysuria, difficulty emptying, and light-headedness.

Physician employment contracts: assessing the value and risks to urologists

"Urologists entering contract discussions with potential employers should have a base understanding of the multiple factors that impact how compensation is structured in physician contracts," writes Yehuda A. Sugarman of the AACU.

LUGPA president: Association will stay vocal in 2020 and beyond

As health care reform and payment policies evolve, LUGPA is ensuring that independent urologists have a strong voice in Washington and the resources they need to sustain successful practices, said Richard G. Harris, MD, LUGPA president, at the association’s 2019 annual meeting in Chicago.

Foray of FPMRS into telemedicine during the coronavirus pandemic

"Patients undergoing midurethral sling placement are ideal for postoperative virtual visits," writes Priya Padmanabhan, MD, MPH.

New recurrent UTI guideline: What urologists need to know

The AUA/CUA/SUFU guide focuses on a combination of symptoms and positive cultures.

A. Lenore Ackerman, MD, on vaginal estrogen for recurrent UTIs

A. Lenore Ackerman, MD, PhD, discusses how clinicians should approach conversations with patients on the risks and benefits of vaginal estrogen.

Teleurology: The time has arrived

This article will discuss obstacles that urologists typically must address when implementing telemedicine into their practice.

Teleurology: The time has arrived

This article will discuss obstacles that urologists typically must address when implementing telemedicine into their practice.

Robotic suprapubic simple prostatectomy: Step-by-step approach

In this video, Nicholas R. Rocco, MD, Michael G. Santomauro, MD, and colleagues, illustrate a safe and effective way to treat a large-volume prostate causing obstructive lower urinary tract symptoms.

Robotic simple suprapubic prostatectomy for large prostatic adenoma

This video from Michael Lao, MD, Jacob A. Baber, MD, and Joseph R. Wagner, MD, depicts a minimally invasive robotic approach for a large symptomatic prostatic adenoma with bladder calculi.

Robotic simple suprapubic prostatectomy for large prostatic adenoma

This video from Michael Lao, MD, Jacob A. Baber, MD, and Joseph R. Wagner, MD, depicts a minimally invasive robotic approach for a large symptomatic prostatic adenoma with bladder calculi.

Robotic simple suprapubic prostatectomy for large prostatic adenoma

This video from Michael Lao, MD, Jacob A. Baber, MD, and Joseph R. Wagner, MD, depicts a minimally invasive robotic approach for a large symptomatic prostatic adenoma with bladder calculi.

Patient selection, key steps for robotic simple prostatectomy

In this video, Stephen Summers, MD, and Ross Anderson, MD, introduce several techniques for treating large prostates with a robot-assisted simple prostatectomy.

Patient selection, key steps for robotic simple prostatectomy

In this video, Stephen Summers, MD, and Ross Anderson, MD, introduce several techniques for treating large prostates with a robot-assisted simple prostatectomy.

Are reusable catheters safe? Study provides an answer

"Patient perception is an important aspect of developing an effective treatment plan, and we should be able to arm patients with accurate data to help them make an informed decision," write Whitney Renee Smith, MD, and Gopal H. Badlani, MD.

A patient’s dignity and daughter-and a race

"Like most doctors, the majority of my day is spent handholding, counseling, relieving anxiety, and otherwise dealing with problems that aren’t necessarily medical," writes urologist Scott Donaldson, MD.

PD-1 inhibitor shows some antitumor activity in prostate cancer

With additional follow-up of approximately 10 months, monotherapy with the PD-1 inhibitor pembrolizumab (Keytruda) continued to show antitumor activity in men with metastatic castration-resistant prostate cancer. However, monotherapy alone is likely not a sufficient treatment in this patient population, according to Emmanuel Antonarakis, MBBCh, professor of oncology at Johns Hopkins University in Baltimore, Maryland.

Analysis suggests survival improved when cytoreductive nephrectomy added to immunotherapy in mRCC

The primary objective of the study was to assess the benefit of cytoreductive nephrectomy relative to immunotherapy regimens utilizing checkpoint inhibitors.

Addressing resident burnout starts with program’s culture

"I was overcome by the sinking notion that my career ambitions were regressing from thriving to surviving-a sentiment I know isn’t unique to my training. What may be unique, however, is how my program responded to increasingly evident signs of resident burnout," says James Anaissie, MD.

Simplifying stent removal coding: Understanding 52310 vs 52315

"Based on the code description, we recommend basing the code selection on the documentation and the effort required to complete the service, and not the number of foreign bodies removed from the bladder," write Jonathan Rubenstein, MD, and Mark Painter.

Robotic ureteroscopy: The future of stone management?

Advances in robotic URS will help target stones and reduce ionizing radiation.

Robotic ureteroscopy: The future of stone management?

Advances in robotic URS will help target stones and reduce ionizing radiation.

Upper tract transitional cell carcinoma: Diagnostic and therapeutic considerations

Determining grade of disease is important, as nephron-sparing approaches may be feasible.

The case for transperineal prostate biopsy vs. the transrectal approach

Reduced infection rate may drive increased use of the transperineal approach.

The case for transperineal prostate biopsy vs. the transrectal approach

Reduced infection rate may drive increased use of the transperineal approach.